Researchers may have uncovered why some patients with Merkel cell carcinoma do not respond to immune checkpoint blockade therapy, according to a recent study published by Reinstein et al in Cancer Discovery.
Background
Merkel cell carcinoma—a rare but highly aggressive type of skin…
[ad_2]
Source link
